These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28520273)

  • 1. Efficacy of a Targeted Drug Delivery on-Demand Bolus Option for Chronic Pain.
    Bolash RB; Niazi T; Kumari M; Azer G; Mekhail N
    Pain Pract; 2018 Mar; 18(3):305-313. PubMed ID: 28520273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longevity and cost of implantable intrathecal drug delivery systems for chronic pain management: a retrospective analysis of 365 patients.
    Bolash R; Udeh B; Saweris Y; Guirguis M; Dalton JE; Makarova N; Mekhail N
    Neuromodulation; 2015 Feb; 18(2):150-5; discussion 155-6. PubMed ID: 25250852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction.
    Brogan SE; Winter NB; Okifuji A
    Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-controlled intrathecal analgesia for the management of breakthrough cancer pain: a retrospective review and commentary.
    Brogan SE; Winter NB
    Pain Med; 2011 Dec; 12(12):1758-68. PubMed ID: 22054042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying a Part of the Daily Dose as Boli May Improve Intrathecal Opioid Therapy in Patients With Chronic Pain.
    Reck T; Chang EC; Béchir M; Kallenbach U
    Neuromodulation; 2016 Jul; 19(5):533-40. PubMed ID: 26856808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal Hydromorphone and Bupivacaine Combination Therapy for Post-Laminectomy Syndrome Optimized with Patient-Activated Bolus Device.
    Hayek SM; Veizi E; Hanes M
    Pain Med; 2016 Mar; 17(3):561-571. PubMed ID: 26814257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of intrathecal drug delivery system for intractable pain in advanced malignancies: A prospective cohort study.
    Zheng S; He L; Yang X; Li X; Yang Z
    Medicine (Baltimore); 2017 Mar; 96(11):e6354. PubMed ID: 28296770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Outcomes Using Intrathecal Drug Delivery Systems in Complex Regional Pain Syndrome.
    Herring EZ; Frizon LA; Hogue O; Mejia JU; Rosenquist R; Bolash RB; Machado AG; Nagel SJ
    Pain Med; 2019 Mar; 20(3):515-520. PubMed ID: 29889241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study.
    Mohammed SI; Eldabe S; Simpson KH; Brookes M; Madzinga G; Gulve A; Baranidharan G; Radford H; Crowther T; Buchser E; Perruchoud C; Batterham AM
    Neuromodulation; 2013; 16(6):576-81; discussion 582. PubMed ID: 23205907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost comparison of intrathecal morphine to intravenous patient-controlled analgesia for the first 24 h post cesarean delivery: a retrospective cohort study.
    Patel N; Bryant A; Duncan K; Kukreja P; Powell MF
    J Anesth; 2017 Feb; 31(1):44-50. PubMed ID: 27743120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain.
    Grider JS; Harned ME; Etscheidt MA
    Pain Physician; 2011; 14(4):343-51. PubMed ID: 21785477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent intrathecal opioid escalation in chronic noncancer pain patients.
    Hayek SM; Veizi IE; Narouze SN; Mekhail N
    Pain Med; 2011 Aug; 12(8):1179-89. PubMed ID: 21810164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost utilization analysis of intrathecal therapy for refractory cancer pain: identifying factors associated with cost benefit.
    Brogan SE; Winter NB; Abiodun A; Safarpour R
    Pain Med; 2013 Apr; 14(4):478-86. PubMed ID: 23461787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal Pumps.
    Ericson T; Singla P; Kohan L
    Phys Med Rehabil Clin N Am; 2022 May; 33(2):409-424. PubMed ID: 35526977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal Morphine Infusion Therapy in Management of Chronic Pain: Present and Future Implementation in Korea.
    Kim EJ; Moon JY; Kim YC; Park KS; Yoo YJ
    Yonsei Med J; 2016 Mar; 57(2):475-81. PubMed ID: 26847303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost Savings of Patient-Controlled Intrathecal Analgesia.
    Bolash RB
    Reg Anesth Pain Med; 2015; 40(5):639-40. PubMed ID: 26288036
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient-Controlled Analgesia Plus Background Opioid Infusion for Postoperative Pain in Children: A Systematic Review and Meta-Analysis of Randomized Trials.
    Hayes J; Dowling JJ; Peliowski A; Crawford MW; Johnston B
    Anesth Analg; 2016 Oct; 123(4):991-1003. PubMed ID: 27065359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
    Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
    Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal Drug Delivery Systems for Noncancer Pain: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(2):1-77. PubMed ID: 27026797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up.
    Atli A; Theodore BR; Turk DC; Loeser JD
    Pain Med; 2010 Jul; 11(7):1010-6. PubMed ID: 20492572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.